Sign in

CIK 0001746466

  • Non-accelerated filer
  • Smaller reporting company

Equillium, Inc.

Sign in to watch
Ticker
EQ
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
821554746
Phone
+1 858-412-5302
Business address
2223 AVENIDA DE LA PLAYA, SUITE 105, LA JOLLA, CA, 92037
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Grant or award Chief Financial Officer acquired 4,444 shares (grant or award)
  4. 4 Grant or award Chief Development Officer acquired 10,065 shares (grant or award)
  5. 4 Derivatives Options or other derivatives
  6. 4 Grant or award Sr. Vice President and COO acquired 9,033 shares (grant or award)
  7. 4 Open-market sale Chief Financial Officer sold 7,000 shares at $2.83 ($19,810)
  8. 4 Open-market sale Chief Financial Officer sold 5,000 shares at $2.52 ($12,600)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Open-market sale Chief Financial Officer sold 8,000 shares at $3.18 ($25,440)
  15. 4 Derivatives Options or other derivatives
  16. 3 Insider Initial Statement of Ownership
  17. 4 Grant or award Chief Financial Officer acquired 5,585 shares (grant or award)
  18. 4 Grant or award Chief Development Officer acquired 1,290 shares (grant or award)
  19. 4 Open-market sale Chief Financial Officer sold 5,000 shares at $5.08 ($25,402)
  20. 4 Open-market sale Sr. Vice President and COO sold 11,434 shares at $5.49 ($62,715)

Page 5 of 9 · 177 filings